We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · October 20, 2022

Maintenance Treatment With Niraparib in Patients With Advanced Urothelial Carcinoma

European Urology


Additional Info

European Urology
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial
Eur Urol 2022 Oct 07;[EPub Ahead of Print], F Vignani, R Tambaro, U De Giorgi, P Giannatempo, D Bimbatti, C Carella, M Stellato, F Atzori, M Aieta, C Masini, A Hamzaj, P Ermacora, A Veccia, G Scandurra, T Gamba, G Ignazzi, S Pignata, M Di Napoli, C Lolli, G Procopio, F Pierantoni, A Zonno, D Santini, M Di Maio

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading